ERIC 2018

The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October.

Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.

4:20
Projections from real world evidence of CLL management
Robin Foà
9:35
Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells
Kanti Rai
2:49
Genomic discoveries in CLL
Richard Rosenquist
3:18
Opinion on MRD in CLL: routine use or clinical trials?
Kanti Rai
3:08
Resistance mechanisms in CLL
Richard Rosenquist
1:52
ERIC’s first International Meeting and plans for the future
Paolo Ghia
1:50
Current ERIC research in the CLL genomics field
Richard Rosenquist
1:44
CLL treatment duration and the role of MRD
Peter Hillmen
6:28
Prognostic markers and MRD in CLL
Robin Foà
2:36
Current knowledge of the TP53 mutation and its role in CLL
Jitka Malcikova
1:37
Progress in CLL diagnosis and treatment
Kanti Rai
1:00
European Research Initiative on CLL (ERIC) International Meetings
Kostas Stamatopoulos
2:13
CLL cell dynamics
Nicholas Chiorazzi
0:51
An update on ERIC initiatives
Paolo Ghia
1:20
Cell-extrinsic biomarkers for CLL: immunogenetic data
Andreas Agathangelidis
3:01
Cell-intrinsic biomarkers in CLL: focus on cytogenetics
Blanca Espinet
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals